NASDAQ Companies - Bay Street News

NASDAQ Companies - October 1, 2020

NeuroStar® Advanced Therapy Providers Offer Free TMS Consultations During National Depression Awareness Month

MALVERN, Pa., Oct. 01, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, […]

NASDAQ Companies - October 1, 2020

Digital Ally Awarded Notable Contract With Fort Eustis Air Force Base

Digital Ally to Provide a Complete Video Solution Including Body Cameras, In-Car Camera Systems with Patented VuLink® Technology and Back-End […]

NASDAQ Companies - October 1, 2020

Vera Bradley Honors Breast Cancer Awareness Month With “Be The Hope” Campaign

Bay Street News

NASDAQ Companies - October 1, 2020

CUMULUS MEDIA Completes Initial Closing of Tower Portfolio Monetization Transaction for $208 Million

ATLANTA, Oct. 01, 2020 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) (the “Company,” “CUMULUS MEDIA,” “we,” “us,” or “our”) […]

NASDAQ Companies - October 1, 2020

Mustang Bio Announces First Patient Dosed in Multicenter Phase 1/2 Clinical Trial of MB-102 (CD123-targeted CAR T Cell Therapy)

Bay Street News

NASDAQ Companies - October 1, 2020

Madrigal Pharmaceuticals Announces Three Abstracts Accepted by The Liver Meeting Digital Experience™, The American Association for the Study of Liver Diseases Meeting in November 2020, including Positive Data from Ongoing Open Label Arm of Resmetirom 52 Week Phase 3 MAESTRO-NAFLD-1 Trial

High accuracy in predicting advanced NASH fibrosis (F2-F3) in Phase 3 MAESTRO-NASH study using clinical characteristics and simple, readily available […]

NASDAQ Companies - October 1, 2020

NeuroStar® Advanced Therapy Providers Offer Free TMS Consultations During National Depression Awareness Month

Digital Ally Awarded Notable Contract With Fort Eustis Air Force Base

Vera Bradley Honors Breast Cancer Awareness Month With “Be The Hope” Campaign

CUMULUS MEDIA Completes Initial Closing of Tower Portfolio Monetization Transaction for $208 Million

Mustang Bio Announces First Patient Dosed in Multicenter Phase 1/2 Clinical Trial of MB-102 (CD123-targeted CAR T Cell Therapy)

Madrigal Pharmaceuticals Announces Three Abstracts Accepted by The Liver Meeting Digital Experience™, The American Association for the Study of Liver Diseases Meeting in November 2020, including Positive Data from Ongoing Open Label Arm of Resmetirom 52 Week Phase 3 MAESTRO-NAFLD-1 Trial

Cerence Celebrates One Year of AI for a World in Motion

Icahn Enterprises L.P. Enters Into Agreement with Brett Icahn

DLH Acquires IBA to Bolster its DoD Health Technology Capabilities

Genetic Technologies Provides Update on COVID-19 Risk Test